Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brain Neoplasms
|
204 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.700 | 0 | ||||||||
Neoplasms
|
1644 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.100 | 0.947 | 19 | 2007 | 2020 | |||||
Adenocarcinoma
|
168 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.080 | 1.000 | 8 | 2007 | 2016 | |||||
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
80 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.070 | 1.000 | 7 | 2013 | 2018 | |||||
Pancreatic carcinoma
|
322 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.050 | 1.000 | 5 | 2004 | 2019 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.040 | 1.000 | 4 | 2011 | 2019 | |||||
Carcinogenesis
|
355 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.040 | 1.000 | 4 | 2012 | 2015 | |||||
Malignant neoplasm of pancreas
|
277 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.040 | 1.000 | 4 | 2004 | 2019 | |||||
Neoplasm Metastasis
|
327 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.040 | 1.000 | 4 | 2010 | 2015 | |||||
Carcinoma of lung
|
1204 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.030 | 1.000 | 3 | 2013 | 2016 | |||||
Lung Neoplasms
|
39 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.030 | 1.000 | 3 | 2009 | 2013 | |||||
Malignant neoplasm of lung
|
1142 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.030 | 1.000 | 3 | 2012 | 2016 | |||||
Immunologic Deficiency Syndromes
|
31 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2005 | 2010 | |||||
melanoma
|
515 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2009 | 2016 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Pancreatic intraepithelial neoplasia
|
11 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2012 | 2014 | |||||
Primary malignant neoplasm of lung
|
981 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Sarcoma
|
42 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2009 | 2012 | |||||
Tumor Progression
|
72 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Adenocarcinoma of pancreas
|
138 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
ADENOMAS AND ADENOCARCINOMAS
|
2 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Adult Soft Tissue Sarcoma
|
3 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Benign Neoplasm
|
7 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Breast Carcinoma
|
2793 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Carcinoma, Signet Ring Cell
|
6 | 0.614 | 0.320 | 17 | 7675151 | missense variant | C/A;T | snv | 8.0E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 |